# Contact Clinic PT-141: Editorial Inquiries About the PT-141 Digest

> Contact Clinic PT-141 with editorial questions or corrections about our PT-141 (bremelanotide) research summaries. We are an editorial publisher — not a clinic, and we offer no medical advice.

For editorial questions, source corrections, or citation queries about our PT-141 research summaries.

## Editorial inquiries

Clinic PT-141 is an editorial project covering the PT-141 (bremelanotide) research literature. Use the form below for editorial questions, citation queries, or corrections — if you believe a study has been summarized inaccurately or a source needs updating, we want to know.

We cannot answer requests for medical advice, dosing guidance, or personal health questions, and we do not respond to inquiries about buying, sourcing, or supplying any compound. We are not a clinic and not a vendor; for any clinical question, please consult a qualified healthcare professional with the prescribing information in hand.

## What to expect

Messages are read as editorial correspondence. A well-sourced correction — a PMID, a DOI, or a label reference — is the fastest way to improve a page, and accuracy is the whole point of this project, so substantiated corrections are genuinely welcome. We do not collect health information and ask that you not send any. This page exists for transparency and accountability about the content, in keeping with how the rest of the site is built.

---

A bright, evidence-tiered launch-board for the PT-141 (bremelanotide) record — the one approved use, the modest benefit, and the nausea-led tolerability cost read first and cited line by line, with the unverified field reports lifted clear of the evidence and stamped as such; an open reading desk, not a clinic, and nothing here dosed, sourced, or sold.